In the 1980s and 1990s, wavelength (WL) was generally considered a predictable parameter for anti-AF efficacy of antiarrhythmic drugs based on numerous studies reporting that both INa and IKr blockers terminated and prevented AF by prolongation of the WL (Figure 1) (5, 108–110). The gene discussed is INA; the disease is atrial fibrillation.